Financial statements Cellpeutics
Balance sheet of Cellpeutics
Company age:
Age:
9 y. 9 m. 14 d.
Share capital:
Share capital:
20 000 PLN
Balance sheet data of CELLPEUTICS
|
Year
|
2023
|
|---|---|
| Total assets | 1 399 885,05 |
| A. Fixed assets | - |
| B. Current assets | 1 399 885,05 |
| C. Share capital contributions (basic funds) | - |
| D. Own shares (stocks) | - |
| Total liabilities | 1 399 885,05 |
| A. Equity | 120 135,41 |
| B. Liabilities and provisions for liabilities | 1 279 749,64 |
| I. Long-term liabilities | - |
| II. Short-term liabilities | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.